Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children

Pediatr Pulmonol. 1998 Aug;26(2):147. doi: 10.1002/(sici)1099-0496(199808)26:2<147::aid-ppul14>3.0.co;2-1.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Child
  • Child, Preschool
  • Deoxyribonuclease I / administration & dosage*
  • Deoxyribonuclease I / adverse effects
  • Expectorants / administration & dosage*
  • Expectorants / adverse effects
  • Female
  • Fever / etiology
  • Humans
  • Hypoxia / etiology
  • Infant
  • Instillation, Drug
  • Intubation, Intratracheal
  • Male
  • Pulmonary Atelectasis / drug therapy*
  • Pulmonary Atelectasis / therapy
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Respiration, Artificial
  • Treatment Outcome

Substances

  • Expectorants
  • Recombinant Proteins
  • DNASE1 protein, human
  • Deoxyribonuclease I